Jim Tananbaum: Steering Foresite Capital Towards Success

Jim Tananbaum is an alumnus of Yale and Harvard, two of the top learning institutions in the world. He received a Bachelor of Science from Yale Unviersity where he also graduated with a Bachelor of Science in Electrical Engineering degree. However, it is at Harvard Medical School that he specialized in a field where he has made a name for himself as a serial investor with a keen eye for top talents industry. He graduated from the school with Doctor of Medicine degree. His three degrees, experience and skills developed over several years of practice has seen him become a leading personality in the healthcare sector where his company, Foresite Capital is carving out a name for itself as a leading provider of innovative, next-generation healthcare solutions. Visit Forbes for more info.

This fete has been achieved through strategically initiatives including hiring key industry talents capable of helping the company breakthrough the highly competitive pharmaceutical market. The hiring of Dr. Molly He is such initiative as he was not only hired but also made a venture partner. The highly experienced company executive and skilled research scientist bring on board not only her years of experience as a scientists; her deep industry knowledge is expected to push the company towards developing next-geenration and innovative pharmaceutical products. More details can be found on Ideamensch.

Serial Investments and Leadership

Jim Tananbaum’s management experience and investment portfolio extend beyond his company, Foresite Capital where he serves as the managing director. Jim has also invested in several companies. He is a serial investor in the pharmaceutical industry. Through Foresite Capital, he invested millions of dollars in several pharmaceutical companies including Jazz Pharmaceuticals. In some cases, he is involved in the management of the companies he has invested in. However, his investments have led to an increase in the value of these companies leading to acquisitions by other entities. He was also a founder of Geltex Pharmaceuticals, which he later sold to Genzyme.

Jim Tananbaum serves on key boards at his alma maters, Yale and Harvard while also working on several boards of the companies he has invested in. he formerly served on the board of directors and executive management teams of several entities Geltex Pharmaceuticals.

See more: http://www.fiercebiotech.com/venture-capital/foresite-capital-reloads-a-450m-biotech-venture-fund